1. [P2–168]: PPID CONTROLS TOXIC AMYLOID FORMATION THROUGH PROLINE ISOMERIZATION. (1st July 2017) Authors: Baker, Jeremy D.; Shelton, Lindsey B.; Zheng, Dali; Blair, Laura J.; Koren, John; Zweckstetter, Markus; Dickey, Chad A. Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 13 Page Start: P671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [P4–103]: PROLINE ISOMERIZATION CONTROLS TOXIC AMYLOID FORMATION. (1st July 2017) Authors: Baker, Jeremy D.; Breydo, Leonid; Dickey, Chad A.; Blair, Laura J.; Koren, John Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 27 Page Start: P1297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Disruptors of the Hsp90/Aha1 complex that reduce tau aggregation: Nonhuman/Lead optimization studies. (7th December 2020) Authors: Keegan, Bradley M; Koren, John; Blagg, Brian S.J. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions. (May 2014) Authors: Jhaveri, Komal; Ochiana, Stefan O; Dunphy, Mark PS; Gerecitano, John F; Corben, Adriana D; Peter, Radu I; Janjigian, Yelena Y; Gomes-DaGama, Erica M; Koren, John; Modi, Shanu; Chiosis, Gabriela Journal: Expert opinion on investigational drugs Issue: Volume 23:Number 5(2014:May) Page Start: 611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hsp90 and FKBP51: complex regulators of psychiatric diseases. (19th January 2018) Authors: Criado-Marrero, Marangelie; Rein, Theo; Binder, Elisabeth B.; Porter, James T.; Koren, John; Blair, Laura J. Journal: Philosophical transactions Issue: Volume 373:Number 1738(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hsp90 and FKBP51: complex regulators of psychiatric diseases. (4th December 2017) Authors: Criado-Marrero, Marangelie; Rein, Theo; Binder, Elisabeth B.; Porter, James T.; Koren, John; Blair, Laura J. Journal: Philosophical transactions Issue: Volume 373:Number 1738(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons. Issue 1 (December 2018) Authors: Kishinevsky, Sarah; Wang, Tai; Rodina, Anna; Chung, Sun; Xu, Chao; Philip, John; Taldone, Tony; Joshi, Suhasini; Alpaugh, Mary; Bolaender, Alexander; Gutbier, Simon; Sandhu, Davinder; Fattahi, Faranak; Zimmer, Bastian; Shah, Smit; Chang, Elizabeth; Inda, Carmen; Koren, John; Saurat, Nathalie; Lei... Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma. Issue 1 (December 2017) Authors: Stothert, Andrew; Suntharalingam, Amirthaa; Tang, Xiaolan; Crowley, Vincent; Mishra, Sanket; Webster, Jack; Nordhues, Bryce; Huard, Dustin; Passaglia, Christopher; Lieberman, Raquel; Blagg, Brian; Blair, Laura; Koren, John; Dickey, Chad Journal: Scientific reports Issue: Volume 7:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies. (September 2011) Authors: Miyata, Yoshinari; Koren, John; Kiray, Janine; Dickey, Chad A; Gestwicki, Jason E Journal: Future medicinal chemistry Issue: Volume 3:Number 12(2011) Page Start: 1523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1–402: Blood‐brain‐barrier–permeable Hsp90 inhibitor reduces soluble tau burden in a mouse model of Alzheimer's disease. (1st July 2013) Authors: Koren, John; Inda, Maria Carmen; Riolo, Matthew; Uddin, Mohammad; Alonso‐Sabadell, Raul; Chiosis, Gabriela Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 7 Page Start: P305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗